Clinical Research Directory
Browse clinical research sites, groups, and studies.
Assessment of Medrol Dosepak to Reduce Opioid Consumption in Foot and Ankle Surgical Patients
Sponsor: Emory University
Summary
This clinical trial aims to determine the effects of a 6-day low-dose methylprednisolone course on pain, nausea, and total opioid consumption in patients undergoing foot and ankle surgeries. The secondary objective of the study is to determine and monitor the effects of the course on complications following surgery and patient-reported outcomes
Key Details
Gender
All
Age Range
18 Years - 95 Years
Study Type
INTERVENTIONAL
Enrollment
180
Start Date
2025-01-27
Completion Date
2027-12
Last Updated
2026-03-09
Healthy Volunteers
No
Interventions
medrol dosepak
Methylprednisolone is a corticosteroid with anti-inflammatory properties and immune suppression. This study will utilize a 6-day Medrol Dosepak: a tapered low-dose corticosteroid course taken orally once a day. This includes 6 tablets on day 1 (24 mg), 5 tablets on day 2 (20 mg), 4 tablets on day 3 (16 mg), 3 tablets on day 4 (12 mg), 2 tablets on day 5 (8 mg) and 1 tablet on day 6 (4 mg).
HYDROcodone Oral Tablet
This study will utilize a prescription of 20 pills of hydrocodone, 5mg each, to be taken as needed for pain, 1 every 6 hours.
Locations (2)
Emory Musculoskeletal Institute, Emory Orthopaedics & Spine Center
Atlanta, Georgia, United States
Emory Sports Medicine Complex and Emory Orthopaedics and Spine Center
Johns Creek, Georgia, United States